Actavis Group PTC Ehf
Records under this name other than the patents Actavis Group PTC Ehf holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,879,867 | Crystalline antifungal compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,354,428 | Novel Solid State Forms of Laquinimod and Its Sodium Salt Formerly held In force · High confidence | In force | High confidence | |
| US 10,251,885 | Azole antifungal compositions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,258,296 | Crystalline antifungal compounds Formerly held Lapsed on the fee record Ended Sep 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 4, 2024 | From the USPTO record |
| US 10,441,536 | Micronized colistimethane sodium pharmaceutical compositions Lapsed on the fee record Ended Oct 15, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 15, 2023 | From the USPTO record |
| US 6,653,475 | Method for preparing pyrimidone derivatives with antifungal activity Formerly held Term ended Term ended Sep 9, 2022 · From the USPTO record | Term ended | Term ended Sep 9, 2022 | From the USPTO record |
| US 8,552,194 | Process for Preparing QUINOLINE-3-Carboxamide Derivatives Lapsed on the fee record Ended Oct 8, 2021 · High confidence | Lapsed on the fee record | Ended Oct 8, 2021 | High confidence |
| US 9,006,443 | Process for preparing quinoline-3-carboxamide derivatives Lapsed on the fee record Ended Apr 14, 2019 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2019 | From the USPTO record |
| US 8,859,769 | Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine Lapsed on the fee record Ended Oct 14, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 14, 2018 | From the USPTO record |
| US 8,314,235 | Process for Preparing Varenicline, Varenicline Intermediates, and Pharmaceutically Acceptable Salts Thereof Lapsed on the fee record Ended Nov 20, 2016 · High confidence | Lapsed on the fee record | Ended Nov 20, 2016 | High confidence |